Thanks for this article. Way to go!
Finally - someone must be listening when I posted that I think the pathology of the cancer has to be important to the researchers other than just the triple negative factor.
"In conclusion, standard adjuvant chemotherapy seems to be less effective in breast cancer with triple negative type and new therapeutic approaches are indicated. Greater understanding of the pathologic and molecular characteristics of this phenotype may lead us to tailor the treatment for these patients. "